To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have CLL, SLL, or NHL that has persisted or returned despite prior therapy.
- Patients should have recovered from the side effects of prior therapies before entering the study.
- Patients must be physically well enough that they are fully ambulatory, capable of all self care, and are capable of all but physically strenuous activities. As an example, patients must be well enough that they would be able to carry out office work or light housework.
- Patients must be age 18 or older.
For more information and to inquire about eligibility for this study, please contact Dr. John Gerecitano at 212-639-3748.